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Three-Dimensional Carotid Ultrasound Plaque Texture
Predicts Vascular Events
Arna van Engelen, PhD; Thapat Wannarong, MD; Grace Parraga, PhD; Wiro J. Niessen, PhD;
Aaron Fenster, PhD; J. David Spence, MD; Marleen de Bruijne, PhD
Background and Purpose—Carotid ultrasound atherosclerosis measurements, including those of the arterial wall and
plaque, provide a way to monitor patients at risk of vascular events. Our objective was to examine carotid ultrasound
plaque texture measurements and the change in carotid plaque texture during 1 year in patients at risk of events and to
compare these with measurements of plaque volume and other risk factors as predictors of vascular events.
Methods—We evaluated 298 patients with carotid atherosclerosis using 3-dimensional (3D) ultrasound at baseline and after
1 year and measured carotid plaque volume and 376 measures of plaque texture. Patients were followed up to 5 years
(median [range], 3.12 [0.77–4.66]) for myocardial infarction, transient ischemic attack, and stroke. Sparse Cox regression
was used to select the most predictive plaque texture measurements in independent training sets using a 10-fold crossvalidation, repeated 5×, to ensure unbiased results.
Results—Receiver operator curves and Kaplan–Meier analysis showed that changes in texture and total plaque volume
combined provided the best predictor of vascular events. In multivariate Cox regression, changes in plaque texture
(median hazard ratio, 1.4; P<0.001) and total plaque volume (median hazard ratio, 1.5 per 100 mm3; P<0.001) were both
significant predictors, whereas the Framingham risk score was not.
Conclusions—Changes in both plaque texture and volume are strongly predictive of vascular events. In high-risk patients, 3D
ultrasound plaque measurements should be considered for vascular event risk prediction.   (Stroke. 2014;45:2695-2701.)
Key Words: carotid arteries ◼ stroke ◼ ultrasound
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T

between symptomatic and asymptomatic subjects6 and has
been used to predict events.7–9 More complex texture measures, with examples given in Table I in the online-only Data
Supplement, provide information on the distribution of pixel
intensities over the plaque. Incorporating such higher order
texture parameters, such as coarseness or contrast, may provide more insight into the underlying tissue properties and
has been used in several studies as well.10–12 In previous studies, these higher order texture measures were shown to differentiate accurately between symptomatic and asymptomatic
subjects10 and performed better than a set of plaque shape
parameters.11 In addition, they were more predictive of events
than a combination of a history of events and plaque parameters, such as plaque area and gray scale median.12
In addition to single time-point measurements, progression of TPV was shown to be a strong predictor of events,2
and changes in plaque texture were more sensitive to statininduced effects than changes in TPV.13 On the basis of all

here is an urgent need for rapid, reliable, and cost-effective methods to monitor patients who are at high risk for
adverse vascular events. Such methods may be used to target
treatment to high-risk patients, thereby preventing vascular
events.1 Ultrasound is a relatively inexpensive and widely
available imaging method enabling quantitative imaging measurements of the carotid artery wall, including intima-media
thickness, vessel wall volume, and plaque burden. It has been
shown that carotid plaque burden measures, such as total
plaque area or total plaque volume (TPV) and their changes
over time, provide strong predictors of adverse events.2
Carotid ultrasound, by means of plaque echogenicity or
texture, also provides a way to measure plaque composition. Lipid cores and intraplaque hemorrhage are thought to
destabilize plaque, whereas calcifications have a stabilizing
effect.3,4 In ultrasound, lipid and hemorrhagic areas are more
echolucent, whereas calcified and fibrous areas are echorich.5
Ultrasound echogenicity has been shown to differentiate
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these findings, we hypothesized that changes in plaque composition over time may be related to subsequent vascular
events. Therefore, here our goal is to develop 3-dimensional
ultrasound (3DUS) plaque texture measurements and to determine whether plaque texture and changes in plaque texture
could improve the prediction of events in high-risk patients.

Methods
Study population, image acquisition and plaque volume annotation
have previously been described.2,14

Study Population
Patients with a history of risk factors, such as hypertension or hyperlipidemia, or with a history of vascular events, who were being followed up in the Stroke Prevention Clinic or the Premature
Atherosclerosis Clinic at the University Hospital, London, Canada,
were enrolled in the study. The inclusion criteria included a baseline
plaque area between 40 and 600 mm2, measured by 2D ultrasound.15
All plaques from the clavicle to the angle of the jaw, including the
right subclavian artery and the common, internal and external carotid
artery were considered. Participants with a stenosis ≥70% on Doppler
ultrasound were excluded, and all subjects provided written informed
consent to a protocol approved by the Western University Human
Research Ethics Board.

Follow-Up for Outcomes
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Participants were followed up for ≤5 years (median [range], 3.12
[0.77–4.66]). At each annual visit, participants were queried about
any events in the previous year. Any report of stroke, transient ischemic attack (TIA), or myocardial infarction (MI) was confirmed by
review of the hospital electronic record. For patients who could not
be contacted to attend for follow-up because they had died, death
and cause of death were confirmed by contact with the primary care
physician. The sonographer who evaluated the images was blinded
with respect to events.

Ultrasound Acquisition
3DUS scans (most common voxel size, 0.21×0.21×0.21 mm; mean,
0.21×0.21×0.33 mm) of both carotid arteries were acquired at baseline and after 1 year (median [range], 364 [226–897] days). The ultrasound transducer (L12-5; 50 mm; Philips, Bothel, WA) was manually
moved along the neck of the patient for 4.0 cm in ≈8 s, imaging ≈30
slices/s, centered around the bifurcation. Video frames were digitized
using 3DEchotec equipment (General Electric Medical Systems,
Hallbergmoos, Germany). The acquired 2D images were reconstructed immediately into a 3DUS image (3DQuantify; Robarts Research
Institute, London, Canada). It was attempted that the same technician
made the baseline and follow-up scan of each patient.

TPV Assessment
For plaque delineation, the 3DUS image was displayed using
3DQuantify. TPV was measured as described previously16 in all scans
by 1 observer (T.W.) who was blinded to the time-point (baseline or
follow-up), patient characteristics, and vascular events. All plaques
between 1.5 cm below the bifurcation and 1.0 cm above the bifurcation into the internal carotid artery were considered. For each plaque,
a plane in the longitudinal view which best visualized the plaque was
selected for defining the length of the plaque and for placing 2 end
points at the proximal and distal ends of the plaque. At 25%, 50%,
and 75% of its length, the boundary of the plaque was annotated perpendicular to the long axis. These boundaries and the end points were
connected by a computer program to create a volume. TPV per patient was measured as the sum of the volume of all plaques present.
For reference, intima-media thickness was measured from longitudinal image planes extracted from the 3DUS images as previously
described,2,17 and repeated 3× per image.

Texture Analysis
A set of 376 texture measures based on 9 different texture extraction
techniques was calculated. Most of the texture measures have previously been used in studies on 2D10–12 and 3D13 carotid ultrasound. An
overview is provided in Table 1 (details can be found in the onlineonly Data Supplement).
Texture was calculated for the annotated plaque volumes in both
arteries. For each measure, the average was calculated by weighting
the values per plaque by the plaque volumes, to obtain 1 value per
patient for each measure, at both baseline and follow-up. For 7 cases
with no plaque in the 3D ultrasound at baseline, baseline texture was
taken as the mean of all other subjects at baseline. Texture measures
were normalized by setting the mean of all subjects to 0 with a SD of
1 for each measure.
Sparse Cox regression was used to combine the 376 texture measures into 1 texture-based risk indicator, using the glmnet toolbox27,28
for R29. With sparse regression, a penalty term promotes the reduction
of the number of parameters in the model, leaving only the strongest
predictors. In our experiments, we fixed the number of remaining parameters in the model to 5 because of the relatively low number of
events.
To ensure unbiased parameter selection, experiments were performed by 10-fold cross-validation, so subjects were randomly divided in 10 equally sized groups with the event incidence equally
divided over those 10-folds. Within cross-validation experiments
the model for combining texture measures was built on 9 of the
10-folds, and used to calculate the hazard ratio (HR) for the subjects in the 10th-fold. This was repeated 10× with each fold left out
once, to obtain an HR for each subject. This HR was used as the
texture-based risk indicator. This was performed both for the 376
baseline texture parameters and for the 376 texture change parameters, which were calculated by subtracting baseline texture from
follow-up texture.
To combine ≥2 parameters (texture/TPV baseline/changes), a Cox
model was built using only those parameters. This was done using
the same 10-fold cross-validation: both the model to combine the
texture measures into 1 risk parameter, and the model to combine
parameters was developed on 9 folds and evaluated on the 10th. All
cross-validation experiments were repeated 5×, to evaluate stability
of the procedure.

Statistical Analysis
Because of non-normality of the studied parameters, continuous variables are given as median and interquartile range, and Kruskal–Wallis
testing was used to test for differences between groups. For categorical variables, a χ2 test was used to compare groups.
The predictive value of the studied parameters was evaluated by
receiver-operating characteristic (ROC) analysis, Kaplan–Meier
analysis, and multivariate Cox regression. For ROC analysis, the area
under the curve was determined for baseline texture, texture change,
baseline TPV and TPV change, and combinations of those measures.
Further analyses focused on texture change and TPV change, and

Table 1.

Texture Measures Used in the Analysis

Method

No. of Features
34

Gray-level distribution

13

Gray-level co-occurrence matrix18

78

19

Gray-level run length matrix

60

Gray-level difference matrix20

12

Neighborhood gray-tone difference matrix21
Law’s texture22

10
105

Local binary pattern23

27

Gaussian filter bank24

24

Structure tensor25,26

20

A more detailed description can be found in the online-only Data Supplement.
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Results

their combination. Kaplan–Meier curves were made after dividing the
participants in 3 equally sized groups of increasing TPV or texture
change (HR). The differences between these groups were tested for
statistical significance by log-rank tests. In addition, the HR of the
high-risk group with respect to the other 2 groups was determined by
Cox regression.
To evaluate the potential effects of the ultrasound-derived measures in combination with other covariates, Cox regression was
performed with change in TPV, change in plaque texture, and the
extended Framingham risk score.30 The extended Framingham
risk score predicts general cardiovascular disease risk, based on
age, sex, high-density lipoprotein and total cholesterol, systolic
blood pressure (treated or untreated), smoking, and diabetes mellitus. Because of skewness of the texture measure, the logarithm
of this measure was used. The full model was compared with
the model without texture change, and the model without TPV
change, using a log-likelihood ratio test. In addition, Cox regression was performed using a stepwise backward Wald approach,
with baseline TPV and texture added as covariates to verify their
predictive value in combination with plaque changes and clinical
parameters.
In all experiments, participants who experienced MI, TIA, or
stroke during follow-up were considered as positive for vascular
events. Statistical analysis was performed using both R (Sparse Cox
regression, ROC, and Kaplan–Meier analysis) and SPSS software
(full Cox regression models).

Table 2.

Patient Characteristics
In total, 298 patients were included for 3DUS analysis. During
follow-up, 27 of these subjects experienced a vascular event,
of which 9 had a stroke, 11 a TIA, and 7 a MI. Two subjects
died as a consequence of the event. Baseline characteristics
are provided in Table 2.

Texture Measures
In Figure 1, 2 of the strongest texture measures (when considering texture change) are shown for a single patient. These 2
measures were most often selected by Cox regression, 49 and
48 of 50 experiments, respectively. The 2 plaques in this vessel
are different in appearance, which is reflected by the 2 texture
images. Table I in the online-only Data Supplement provides
the 6 most often selected texture measures as selected by sparse
Cox regression, alongside with texture change and TPV change,
and their values in patients who do or do not experience a vascular event for reference. In practice, only these strongest texture
parameters need to be calculated, on which the risk parameter
can be determined and compared with reference values.

Baseline Characteristics
Without Event (n=271)*

Age, y
Men, %
Systolic blood pressure, mm Hg
Downloaded from http://ahajournals.org by on March 3, 2020

Diastolic blood pressure, mm Hg

70 (64–77)

With Event (n=27)*
75 (64–80)

P Value†
0.30

58

52

0.54

134 (122–149)

131 (114–142)

0.11

69 (62–78)

0.17

74 (66–82)

IMT, mm

0.92 (0.82–1.04)

0.93 (0.84–0.98)

0.74

TPV, mm3

273 (191–437)

253 (119–422)

0.21

40 (40–50)

40 (40–40)

0.26

Stenosis, %
BMI
Smoking (never, quit, and still smoking)
Smoking pack-years

27.9 (25.5–31.5)

29.0 (25.3–31.8)

0.96

36%, 56%, and 8%

33%, 48%, and 19%

0.74, 0.45, and 0.06

15 (0–28)

0.34

Total cholesterol, mmol/L

3.9 (3.4–4.7)

5 (0–24)

4.1 (3.5–4.9)

0.35
0.85

HDL cholesterol, mmol/L

1.3 (1.1–1.7)

1.3 (1.1–1.8)

LDL cholesterol, mmol/L

1.9 (1.5–2.5)

2.1 (1.5–2.6)

0.30

Triglycerides, mmol/L

1.2 (0.9–1.7)

1.1 (0.9–1.8)

0.77

Framingham risk score

16 (13–18)

15 (13–19)

0.61

Diabetes mellitus, %

21

19

0.79

Previous stroke, %

22

33

0.19

Previous TIA, %

42

56

0.18

Previous MI, %

14

26

0.11
0.31

Previous atrial fibrillation, %

9

15

Previous endarterectomy, %

7

4

0.48

Previous carotid angioplasty, %

1

4

0.26

Previous peripheral artery angioplasty, %

1

4

0.26

7

11

0.44

CABG, %

Previous coronary angioplasty, %

10

15

0.47

Taking antihypertensive drug, %

89

93

0.52

BMI indicates body mass index; CABG, coronary artery bypass graft; HDL, high-density lipoprotein; IMT, intima-media
thickness; LDL, low-density lipoprotein; MI, myocardial infarction; TIA, transient ischemic attack; and TPV, total plaque
volume.
*Continuous variables are given as median (interquartile range); categorical variables are given as percentages.
†P values using Kruskal–Wallis testing for continuous variables and χ2 testing for categorical variables.
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Kaplan–Meier Analysis
Figure 3 shows Kaplan–Meier curves for TPV change, texture
change, and their combination. Threshold values of the HRs
for separating the medium-risk tertile from the low-risk and
high-risk tertiles were −21 and 59 mm3 for TPV change, 0.9
and 1.1 for texture change, and 0.7 and 1.3 for their combination. The difference between risk tertiles was significant for
all experiments (P=0.039 for TPV change; P≤0.01 for texture
change; and P<0.001 for the combination).
Comparing the high-risk tertile with the combined low-risk
and medium-risk tertiles with Cox regression, showed a HR
of 2.3 (P=0.03) for TPV change, 4.3 (2.7–6.4) with P<0.001
to 0.01 for texture change, and 6.2 (4.2–7.9) with P<0.001 for
the combination.

Cox Regression

Figure 1. Texture for 2 plaques in the same vessel with a different appearance. In a total of 50 runs of sparse Cox regression
(5× 10-fold cross-validation) on changes in texture, Laws edgeedge-ripple (EER) was selected in the model 49 times, and laws
spot-spot-ripple (SSR) 48 times.
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ROC Analysis
In Figure 2A, ROC curves are shown for baseline TPV and
texture and change in intima-media thickness, TPV, and
texture. Figure 2B shows ROC curves when ≥2 features are
combined.

Table 3 shows the results for Cox regression with TPV change,
texture change, and the Framingham risk score. Both TPV
change and texture change were significant predictors of stroke,
TIA, and MI, whereas in this data set the Framingham risk score
was not. The log-likelihood ratio tests indicated that the full
model was significantly better than the model excluding texture
change and the model excluding TPV change (all P<0.01).
Table II in the online-only Data Supplement shows 3 additional subanalyses. When only stroke and TIA are considered
as events, TPV change (HR, 1.5; P≤0.007) and texture change
(HR, 1.4; P≤0.003) remain the only significant parameters
in the model. Moreover, after exclusion of 7 patients without plaque at the 3DUS baseline image (TPV change: HR,
1.5; P≤0.001 and texture change: HR, 1.6; P≤0.001) and after
exclusion of 28 patients with atrial fibrillation at baseline
(TPV change: HR, 1.7; P<0.001 and texture change: HR, 1.5;
P≤0.003), results were similar as well.

Figure 2. Receiver-operating characteristic curves for the prediction of vascular events. Black bars represent the SE of the 5 repetitions.
A, Area under the curve (AUC) is 0.57 for baseline (BL) total plaque volume (TPV), 0.68±0.01 for BL texture, 0.57 for intima-media thickness (IMT) change, 0.72 for TPV change, and 0.74±0.02 for texture change. B, AUC is 0.71±0.02 for the combination of BL TPV and
TPV change, 0.75±0.03 for BL texture and texture change, 0.66±0.02 for BL texture and TPV, 0.78±0.02 for texture and TPV change,
0.78±0.01 for BL texture and TPV change, 0.79±0.02 for BL texture and texture and TPV change, and 0.78±0.02 for all 4 parameters: BL
texture and TPV and texture and TPV change. Δ indicates change.
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For backward Wald analysis, including baseline TPV, baseline texture, TPV change, texture change, and the Framingham
risk score in all 5 experiments, TPV change (P≤0.001; HR,
1.4–1.5) and texture change (P≤0.003; HR, 1.3–1.5) were the
only 2 remaining parameters.

Discussion
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Figure 3. Kaplan–Meier curves of event-free survival for 3 tertiles
for (A) total plaque volume (TPV) change, (B) texture change, and
(C) the combination of TPV and texture change. The number of
events per tertile, as median (range), is given for the 3 different
models. For all 3 methods, the difference between tertiles is significant: P=0.039 for TPV change, P≤0.01 for texture change, and
P<0.001 for the combination of TPV change and texture change.

This study compared the predictive value for vascular events
of texture and TPV derived from 3D carotid ultrasound.
Changes in 3DUS texture characteristics and TPV over time
were stronger predictors than baseline variables. Both texture
and TPV change remained significant predictors after adjustment for the Framingham risk score. The full model was significantly better than the model including only TPV or texture
change and the Framingham risk score.
The predictive value of TPV change over time2 and baseline
texture12 have been evaluated previously, but to our knowledge
this is the first study to consider changes in texture and to
combine texture change and TPV change for risk stratification of patients over time. Texture change was more predictive
of events than baseline texture, which suggests that plaques
that are changing faster impose a higher risk on patients than
plaques that are stable in texture and by analogy, stable in
composition. This notion is also supported by the observation that in our analysis, for all texture measures that were
selected, the median change is closer to zero for patients not
experiencing an event than for those who do (Table I in the
online-only Data Supplement). Moreover, this is analogous to
recent findings that plaque changes, such as TPV progression2
or fastest intima-media thickness progression over several
vessel segments,31 are predictive of events.
Framingham risk score was not predictive of events in this
data set. This could be explained by the inclusion that was
based on the presence of carotid plaque and risk factors or
symptoms. All included patients had an increased Framingham
risk score (interquartile range, 13–18). Here, we show that in
a population with increased risk, plaque measurements using
ultrasound can further stratify patients.
In a previous study where statin-induced changes were better reflected by texture change than by TPV change,13 Law’s
texture measures performed best, which is similar to our findings. Moreover, neighborhood gray-tone difference matrix
coarseness was important in our study and was among the
best measures in previous work that showed the discrimination between symptomatic and asymptomatic patients.11
Our findings can be used both for patient monitoring and
evaluation of therapies. The present study shows that including plaque texture in the monitoring of patients contributes to
improved risk assessment using ultrasound. A yearly followup, including ultrasound in an atherosclerosis clinic, is practically feasible.32 More regular follow-up of high-risk patients
would be possible to enable adjustment of therapy in a more
timely fashion. Adjusting patient treatment based on changes
in plaque area instead of traditional risk factors was already
shown to reduce the number of vascular events significantly.33
Including changes in TPV and texture could further improve
effectiveness of patient management. In addition, cost-effective measurements are needed to evaluate newly developed
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Table 3.

Results for Cox Regression
Individual Model

Foundation of Canada (Ontario), grant number NA5912. Arna van
Engelen received additional funding from the Erasmus trust fund.

Full Model

Parameter

P Value

HR

P Value, Median
(Range)

HR, Median
(Range)

Texture change
(per 0.1 change
in log [HR])

<0.001

1.4 (1.3–1.5)

≤0.002

1.4 (1.3–1.5)

TPV change
(per 100 mm3)

<0.001

1.5

≤0.001

All 1.5

0.31

1.1

0.17 (0.14–0.19)

All 1.1

Framingham risk
score

For texture change and for the full model, the HRs and P values are given
with median and range of the 5 repetitions of calculating the texture-based risk
indicator. HR indicates hazard ratio.
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therapies, where imaging parameters will be a good secondary
end point as an alternative to the number of events for which
larger studies and longer follow-up are required.
When MI was left out as an end point, no relevant changes in
the HR of both texture change and TPV change were observed
in Cox regression. The number of MIs was too small to study
the effect for MI only, but these findings are supported by the
notion that vascular disease is systemic, and that carotid atherosclerosis may estimate and reflect disease in other vessels
accurately.34,35
A limitation of this study is the relatively small number
of events. However, the finding that TPV change and texture
change are both significant predictors of events even in this
relatively small data set supports the use of such ultrasoundderived measures when compared with traditional risk factors.
It should be noted that these results hold only for subjects with
identified carotid atherosclerosis, which is a clinically relevant
population. In addition, the sensitivity of the proposed method
to the used imaging equipment and settings has to be evaluated. Finally, it is important to acknowledge that to incorporate plaque texture into clinical practice and large clinical
studies, automated analysis will be required. In the present
study, plaque volumes were segmented semiautomatically, as
described previously,16 but automatic methods are also available,36 which will help facilitate translation to clinical practice.

Conclusions
Changes in ultrasound plaque texture and volume are predictors of vascular events in patients in whom traditional risk factors measured by the Framingham risk score are not. These
measures can be used in clinical practice as a cost-effective
way to monitor high-risk subjects or as an evaluation measure
in the development of new therapies.
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